Drug recall · October 15, 2025
Norgestimate and Ethinyl Estradiol Tablets recall
Why: Failed Content Uniformity Specifications
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Norgestimate and Ethinyl Estradiol Tablets, USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg, 3 Units, 3x28 tablets blister cards per carton, Rx only, Manufactured for AvKARE, Pulaski, TN 38478. Carton NDC: 42291-565-84; Blister NDC: 42291-565-28
- Lots / codes
Lot # LF41138A; Exp 06/30/2027
- Quantity
- 2192 cartons
- Company
- AvKARE, Pulaski, TN
- Distribution
- U.S. Nationwide
- Initiated
- September 2, 2025 · Voluntary: Firm initiated
- Classified
- October 6, 2025
- Reported
- October 15, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Estradiol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.